MedPath

Hemodynamically Important Patent Ductus Arteriosus in Newborns Under 32 Weeks

Recruiting
Conditions
Patent Ductus Arteriosus After Premature Birth
Interventions
Diagnostic Test: Echocardiography, Doppler ultrasonography, Near-infrared spectroscopy
Registration Number
NCT05686343
Lead Sponsor
Ankara University
Brief Summary

To define the characteristics of hemodynamically significant PDA by echocardiography, to investigate the systemic effects of the ductus with cerebral and renal Doppler flow studies, and to determine the oxygen consumption in the cerebral tissue with NIRS in newborns below 32 weeks of age with PDA.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
70
Inclusion Criteria
  • Born at less than 32 weeks newborns
Exclusion Criteria
  • Congenital heart disease
  • Syndromic and/or major congenital anomaly

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
TreatedEchocardiography, Doppler ultrasonography, Near-infrared spectroscopy-
UntreatedEchocardiography, Doppler ultrasonography, Near-infrared spectroscopy-
Primary Outcome Measures
NameTimeMethod
Velocity of internal carotid arteries, middle carotid arteries, anterior cerebral arteries and renal arteries1 year

Measurement velocity of internal carotid arteries, middle carotid arteries, anterior cerebral arteries and renal arteries using doppler ultrasonography

Velosity of PDA1 year

Measurement the velosity of ductus using CW doppler on ecocardiyograpy

Left ventricule expansion1 year

Measurement left ventricule end diastolic and end systolic diameter, left atrium/aort ratio on ecocardiography

Diameter of PDA1 year

Measurement the diameter of ductus in mm/weight using echocardiography

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Özlem Bayram

🇹🇷

Ankara, Turkey

© Copyright 2025. All Rights Reserved by MedPath